Skip to content

Drug interactions

Dabrafenib + Pazopanib

Severity: Moderate

Dabrafenib and Pazopanib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dabrafenib is a CYP3A4 inducer and can lower pazopanib plasma concentrations. This may compromise pazopanib efficacy.

What this interaction means in plain words

Dabrafenib and Pazopanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dabrafenib belongs to Oncology; Pazopanib belongs to Oncology.

Evidence level: Moderate

Why it happens

Dabrafenib induces CYP3A4, increasing pazopanib metabolism.

What to do

Monitor for reduced pazopanib effect and review whether the combination is needed. Avoid empirical pazopanib dose escalation without specialist guidance.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dabrafenib and Pazopanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dabrafenib with Pazopanib?

MediHelp rates the interaction as moderate. Dabrafenib and Pazopanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dabrafenib is a CYP3A4 inducer and can lower pazopanib plasma concentrations. This may compromise pazopanib efficacy.

How serious is the interaction between Dabrafenib and Pazopanib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced pazopanib effect and review whether the combination is needed. Avoid empirical pazopanib dose escalation without specialist guidance.

What other medicines interact with Pazopanib?

MediHelp also lists interactions of Pazopanib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Pazopanib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in